Literature DB >> 9697062

Autologous pericardium for ventricular septal defect closure.

P H Schoof1, M G Hazekamp, K van Ulzen, M M Bartelings, J A Bruyn, W Helbing, H A Huysmans.   

Abstract

BACKGROUND AND AIMS OF THE STUDY: The use of living, untreated autologous pericardium for patch repair in the left ventricular outflow tract was considered attractive in children.
METHODS: Ventricular septal defect (VSD) closure with an untreated autologous pericardial patch was performed in 102 children of mean age 13.4 months (range: 1 to 73 months). Postoperative transthoracic Doppler echocardiography was performed in all children at a mean of nine weeks (range: one day to 50 weeks) after surgery. One pericardial patch, which was explanted at autopsy two months after surgery, was studied microscopically.
RESULTS: At short-term follow up, no or only minor residual VSD was found in 97 patients, moderate VSD in two and severe VSD in one patient. One patient was reoperated for residual VSD and an aneurysmic patch first diagnosed seven days after surgery. Two more patients showed ballooning of the patch without VSD after five and seven days respectively. All aneurysmic patches were attributed to intraoperative patch oversizing. Patch integrity was confirmed in all other patients. No inflammatory or degenerative changes were observed at microscopy, rather a remodeling response had caused the patch to thicken, indicating an adaptation of the living tissue.
CONCLUSIONS: The untreated autologous pericardial patch has shown to be a safe alternative for VSD closure, provided that the patch is properly sized.

Entities:  

Mesh:

Year:  1998        PMID: 9697062

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  5 in total

Review 1.  Bioengineered tissue solutions for repair, correction and reconstruction in cardiovascular surgery.

Authors:  Laura Iop; Tiziana Palmosi; Eleonora Dal Sasso; Gino Gerosa
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

2.  Evaluation of a tissue-engineered bovine pericardial patch in paediatric patients with congenital cardiac anomalies: initial experience with the ADAPT-treated CardioCel(R) patch.

Authors:  William M L Neethling; Geoff Strange; Laura Firth; Francis E Smit
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-07-06

3.  Reoperation for prosthetic ventricular septal defect patch endocarditis: long-term results with an autologous atrial septal patch.

Authors:  Takako Miyazaki; Masaaki Yamagishi; Hitoshi Yaku
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-11-15

4.  Congenital heart defect repair with ADAPT tissue engineered pericardium scaffold: An early-stage health economic model.

Authors:  Vladica M Veličković; Oleg Borisenko; Mikael Svensson; Tim Spelman; Uwe Siebert
Journal:  PLoS One       Date:  2018-09-27       Impact factor: 3.240

Review 5.  Biofabrication in Congenital Cardiac Surgery: A Plea from the Operating Theatre, Promise from Science.

Authors:  Laszlo Kiraly; Sanjairaj Vijayavenkataraman
Journal:  Micromachines (Basel)       Date:  2021-03-21       Impact factor: 2.891

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.